Reviva Pharmaceuticals Holdings Inc [NASDAQ: RVPH] price surged by 28.48 percent to reach at $0.47.
The one-year RVPH stock forecast points to a potential upside of 86.32. The average equity rating for RVPH stock is currently 1.67, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Guru’s Opinion on Reviva Pharmaceuticals Holdings Inc [RVPH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RVPH shares is $15.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RVPH stock is a recommendation set at 1.67. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
ROTH MKM have made an estimate for Reviva Pharmaceuticals Holdings Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 20, 2023. While these analysts kept the previous recommendation, The Benchmark Company raised their target price to Speculative Buy. The new note on the price target was released on June 08, 2023, representing the official price target for Reviva Pharmaceuticals Holdings Inc stock. Previously, the target price had yet another raise to $10, while H.C. Wainwright analysts kept a Buy rating on RVPH stock.
RVPH Stock Performance Analysis:
Reviva Pharmaceuticals Holdings Inc [RVPH] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 76.67. With this latest performance, RVPH shares gained by 125.32% in over the last four-week period, additionally plugging by 46.21% over the last 6 months – not to mention a drop of -48.17% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RVPH stock in for the last two-week period is set at 80.05, with the RSI for the last a single of trading hit 87.14, and the three-weeks RSI is set at 74.27 for Reviva Pharmaceuticals Holdings Inc [RVPH]. The present Moving Average for the last 50 days of trading for this stock 1.2200, while it was recorded at 1.5300 for the last single week of trading, and 1.7900 for the last 200 days.
Insight into Reviva Pharmaceuticals Holdings Inc Fundamentals:
Reviva Pharmaceuticals Holdings Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.39 and a Current Ratio set at 0.39.
Reviva Pharmaceuticals Holdings Inc [RVPH] Institutonal Ownership Details
There are presently around $30.07%, or 35.28%% of RVPH stock, in the hands of institutional investors. The top three institutional holders of RVPH stocks are: WOODLINE PARTNERS LP with ownership of 1.59 million shares, which is approximately 6.6273%. MILLENNIUM MANAGEMENT LLC, holding 1.24 million shares of the stock with an approximate value of $$1.59 million in RVPH stocks shares; and MILLENNIUM MANAGEMENT LLC, currently with $$1.31 million in RVPH stock with ownership which is approximately 4.2659%.
